Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00124202 · ClinicalTrials.gov registry record · Phase 1
Effect of a Fatty Meal on Endoscopic Retrograde Cholangiopancreatography (ERCP)
A Phase 1 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT00124202: Completed Phase 1 study, sponsored by Emory University.
NCT00124202 is a Phase 1 study that has completed, run by Emory University. The registered enrollment target is 80 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00124202, a Phase 1 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study is to determine if a fatty meal would improve the ERCP procedure.
Interventions
- BEHAVIORAL a fatty meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2003-05 |
| Est. Completion | 2007-05 |
| Phase | Phase 1 |
What the finished NCT00124202 record still lists
NCT00124202 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher).
The record links to 0 conditions, and to 1 intervention - of which a fatty meal is the first listed.
NCT00124202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00124202 about?
NCT00124202 is a clinical study titled "Effect of a Fatty Meal on Endoscopic Retrograde Cholangiopancreatography (ERCP)". This study is to determine if a fatty meal would improve the ERCP procedure.
What is the current status of trial NCT00124202?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2003-05. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00124202?
The interventions under investigation include: a fatty meal (BEHAVIORAL).
Who is sponsoring clinical trial NCT00124202?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00124202's enrollment target sits among peer trials
80 672nd of 2000 higher than 1,305 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia